VRTX - Vertex Pharmaceuticals Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts21212323
Avg. Estimate0.740.823.184.56
Low Estimate0.570.652.853.5
High Estimate0.881.033.525.83
Year Ago EPS0.390.531.953.18
Revenue EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts19192323
Avg. Estimate679.26M716.26M2.8B3.42B
Low Estimate650M643.32M2.72B3.05B
High Estimate722.1M779.02M2.97B3.98B
Year Ago Sales544.13M578.16M2.17B2.8B
Sales Growth (year/est)24.80%23.90%28.80%22.20%
Earnings History6/29/20179/29/201712/30/20173/30/2018
EPS Est.0.350.310.530.63
EPS Actual0.390.530.610.76
Difference0.040.220.080.13
Surprise %11.40%71.00%15.10%20.60%
EPS TrendCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Current Estimate0.740.823.184.56
7 Days Ago0.740.823.24.51
30 Days Ago0.740.823.24.56
60 Days Ago0.710.823.044.53
90 Days Ago0.710.813.024.55
EPS RevisionsCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesVRTXIndustrySectorS&P 500
Current Qtr.89.70%N/AN/A0.42
Next Qtr.54.70%N/AN/A0.45
Current Year63.10%N/AN/A0.21
Next Year43.40%N/AN/A0.10
Next 5 Years (per annum)66.50%N/AN/A0.11
Past 5 Years (per annum)48.98%N/AN/AN/A